While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

PFE Quantitative Stock Analysis June 03, 2025 — 09:36 am EDT. Written by John Reese for Validea-> Below is Validea's guru fundamental report for PFIZER INC . Of ...

A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most ...

The Pfizer stock's long-term trajectory looks predominantly bullish, as indicated in the quarterly chart. A closer look shows that between 1999 and 2009, there was a clear emergence of a bull flag ...

Pfizer Inc.'s technical indicators have shifted from bullish to bearish, with the stock now trading below its 30-week EMA and showing bearish momentum. Volume analysis indicates recent ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

See our analysis on Pfizer Stock Chances of Rise for more details. Even if we were to look at our Pfizer’s Valuation, with an EPS estimate of around $4.40 and a P/E multiple of around 13x in ...

Concurrently, Pfizer released topline results from the final prespecified overall survival (OS) analysis of the TALAPRO-2 study of Talzenna (talazoparib) in combination with Xtandi (enzalutamide ...